A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
“We tested the antibody in various ways, including on tumour cells from myeloma patients that have been transplanted into mice. The tests showed that the antibody is able to destroy myeloma cells”, explains Markus Hansson, a researcher at Lund University in Sweden.
Using a ‘biological library’ of thousands of antibodies from the company BioInvent in Lund, the team singled out antibody BI-505, shown to have a powerful effect on the tumour cells in both cell studies and animal experiments. It has also been tested in an initial safety study on seriously ill patients, and a study of its treatment effects has just started.
“This study will include patients who have just been diagnosed and therefore still feel fairly well. We want to test the antibody treatment before the patients are treated with any other drugs”, says Markus Hansson.
Today there are a number of drugs to treat multiple myeloma, but no cure. None of the drugs are able to eradicate the disease, meaning cancer cells increase in number after a period of remission. Survival has been extended with new treatments, but less than half of all patients live longer than five years from diagnosis.
Myeloma occurs when a specific type of cell in the bone marrow is converted into tumour cells. Blood formation is disrupted and patients suffer from a lack of blood resulting in fatigue. The bones can be weakened with a risk of fractures and compacted vertebrae, and patients sometimes suffer kidney failure as a result of the disease.
Antibodies are a part of the immune system, fighting off foreign bodies. Antibody-based drugs are now used to treat certain inflammatory diseases and types of cancer.
The treatment study in Lund will involve 15 patients and is expected to be completed this year.
The Latest Bing News on:
Multiple myeloma
- Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myelomaon April 27, 2024 at 12:00 pm
A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men.
- Cancer patient has ground-breaking new treatment at Colchester Hospitalon April 27, 2024 at 5:00 am
A MULTIPLE myeloma patient has participated in a research study offering an alternative drug treatment at Colchester Hospital. The MajesTEC-9 study, exploring different medication options for bone ...
- International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18on April 25, 2024 at 5:45 am
With Over $675,000 Raised, the Gala Benefits the Peter Boyle Research Fund and Celebrates Groundbreaking Myeloma Research, Education, Support, and AdvocacySTUDIO CITY, Calif., April 25, 2024 (GLOBE ...
- Nurse Suggests Questions to Ask Before Carvykti Treatment for Myelomaon April 24, 2024 at 2:00 pm
With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers before treatment, a nurse said.
- Carvykti Provides Good Long-Term Quality of Life in Pretreated Myelomaon April 24, 2024 at 12:00 pm
Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.
- Study points to racial and social barriers that block treatment for multiple myelomaon April 23, 2024 at 1:15 pm
A UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplant treatment to halt the progression of multiple myeloma.
- NICE recommends Menarini’s Nexpovio combination to treat multiple myelomaon April 22, 2024 at 4:43 am
The National Institute for Health and Care Excellence (NICE) has recommended Menarini Stemline UK’s Nexpovio (selinexor) as part of a combination treatment for multiple myeloma patients who have ...
- NICE backs wider NHS use of multiple myeloma drug Nexpovioon April 22, 2024 at 4:40 am
Nexpovio (selinexor) – which is sold as Xpovio in some markets – is a first-in-class nuclear export XPO1 inhibitor that was approved last year by the MHRA in combination with Velcade Janssen-Cilag’s ...
- NICE recommends Nexpovio for multiple myeloma patients, addressing treatment gapson April 22, 2024 at 4:17 am
In a significant development for the multiple myeloma community, Menarini Stemline UK today welcomed the final draft guidance from the National Institute for Health and Care Excellence (NICE).
- The Myeloma Trial Result I Did Not See Comingon April 17, 2024 at 8:00 am
A new drug called belantamab mafodotin significantly improved survival in relapsed multiple myeloma patients compared to a standard treatment.
The Latest Google Headlines on:
Multiple myeloma
[google_news title=”” keyword=”Multiple myeloma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cancer of the blood
- Mum fighting cancer had arm 'full of blood clots' she thought would kill heron April 27, 2024 at 6:18 am
Fiona 'Fi' Donnison, 47, from Edinburgh said that she had three operations after breast cancer was diagnosed as well as radiotherapy but she thought it was a blood clot that was going to kill her ...
- Rising Prevalence of Blood-Related Diseases Fuels Blood Temperature Indicator Market Growthon April 26, 2024 at 3:15 am
The market for blood temperature indicators is expected to reach US$ 210 million by 2021. According to estimates, blood temperature indicators will generate US$ 235 million in sales by 2022, growing ...
- Patients died after errors by blood cancer serviceon April 24, 2024 at 10:22 pm
Four people have died following errors in Birmingham blood cancer services, the BBC can reveal. The latest deaths, in 2023 at University Hospitals Birmingham (UHB), have prompted an inquiry by The ...
- New Test Detects Cancer In Minutes Using Just 1 Drop of Dried Bloodon April 24, 2024 at 6:04 am
A test devised in Shanghai could make cancer detection quicker, easier, and practical for multiple areas of the body at once. Using just one drop of dried blood, the test looks for biomarkers that ...
- AI can detect 3 of the deadliest cancers in minutes – from just one drop of dried bloodon April 24, 2024 at 5:32 am
AN AI-POWERED test could detect three major types of cancer using just a drop of dried blood, a study suggests. The tool could spot bowel, stomach and pancreatic cancers within minutes, Chinese ...
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- Arthritis linked to blood cancer mutationson April 23, 2024 at 10:20 am
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
- Aspirin Helps the Immune System Fight Canceron April 23, 2024 at 8:20 am
The findings may offer a complementary mechanism for preventing the development and progression of various cancers.
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hintson April 22, 2024 at 9:19 am
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
- Breakthrough blood tests open new frontiers in cancer detectionon April 16, 2024 at 3:20 pm
A series of cutting-edge blood tests have ignited excitement among cancer specialists, promising a new era in oncology by detecting malignancies that previously went unnoticed until they reached ...
The Latest Google Headlines on:
Cancer of the blood
[google_news title=”” keyword=”cancer of the blood” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
